On December 16, 2024, Yeganeh Reuven, Chief Executive Officer of Nukkleus, acquired 10,000 shares of the company's common stock at $1.39 per share. The transaction was executed as a grant, award, or other acquisition, resulting in a total value of $13,900.Following this transaction, Reuven's direct ownership in Nukkleus increased to 10,000 shares. The acquisition was reported as completed, with all shares being held directly by the CEO. This stock purchase aligns the executive's interests more closely with those of the company's shareholders.The transaction details were disclosed in a regulatory filing, providing transparency to investors about insider stock movements. Such acquisitions by company executives are often viewed as a positive signal, potentially indicating confidence in the company's future prospects.

On December 16, 2024, Yeganeh Reuven, Chief Executive Officer of Nukkleus, acquired 10,000 shares of the company's common stock at $1.39 per share. The transaction was executed as a grant, award, or other acquisition, resulting in a total value of $13,900.Following this transaction, Reuven's direct ownership in Nukkleus increased to 10,000 shares. The acquisition was reported as completed, with all shares being held directly by the CEO. This stock purchase aligns the executive's interests more closely with those of the company's shareholders.The transaction details were disclosed in a regulatory filing, providing transparency to investors about insider stock movements. Such acquisitions by company executives are often viewed as a positive signal, potentially indicating confidence in the company's future prospects.